Company No: SC839221 (Scotland)

Contents

• Company Information
• Balance Sheet
• Notes to the Financial Statements

For the financial period ending 28 February 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial period in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
• These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
• These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Deeside Cardiology Ltd (registered number: SC839221) were approved and authorised for issue by the Board of Directors on 24 May 2026 and were signed on its behalf by:

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in Scotland (Company no. SC839221). The address of its registered office is C/O Johnston Carmichael Bishop's Court, 29 Albyn Place, Aberdeen, AB10 1YL, Scotland, United Kingdom.

2. Employees

3. Directors’ benefits: advances, credit and guarantees

Advances

Advances totalling £3,250 were made by the directors in this period and £100 was repaid. No interest is charged in the current year. At 28 February 2026, the company owed £3,150 to the directors.

This loan is unsecured and repayable on demand.